These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4756131)

  • 41. Reconstruction of the nigrostriatal dopamine pathway by intracerebral nigral transplants.
    Björklund A; Stenevi U
    Brain Res; 1979 Nov; 177(3):555-60. PubMed ID: 574053
    [No Abstract]   [Full Text] [Related]  

  • 42. Relation between rotation in the 6-OHDA lesioned rat and dopamine loss in striatal and substantia nigra subregions.
    Olds ME; Jacques DB; Kopyov O
    Synapse; 2006 Jun; 59(8):532-44. PubMed ID: 16565974
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proceedings: Differences in circling responses following electrolytic and 6-hydroxydopamine lesions of the nigro-striatal pathway.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Br J Pharmacol; 1975 Oct; 55(2):289P-290P. PubMed ID: 1238135
    [No Abstract]   [Full Text] [Related]  

  • 44. Acetylcholinesterase in the substantia nigra and caudate-putamen of the rat: properties and localization in dopaminergic neurons.
    Lehmann J; Fibiger HC
    J Neurochem; 1978 Mar; 30(3):615-24. PubMed ID: 681936
    [No Abstract]   [Full Text] [Related]  

  • 45. Behavioral effects of direct- and indirect-acting dopaminergic agonists.
    Moore KE
    Adv Biochem Psychopharmacol; 1974; 12(0):403-14. PubMed ID: 4371765
    [No Abstract]   [Full Text] [Related]  

  • 46. Monoamine oxidase and aldehyde dehydrogenase activity in the striatum of rats after 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Agid Y; Javoy F; Youdim MB
    Br J Pharmacol; 1973 May; 48(1):175-8. PubMed ID: 4724190
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Catecholamines and convulsions.
    Mason ST; Corcoran ME
    Brain Res; 1979 Jul; 170(3):497-507. PubMed ID: 466425
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid increase of Nurr1 expression in the substantia nigra after 6-hydroxydopamine lesion in the striatum of the rat.
    Ojeda V; Fuentealba JA; Galleguillos D; Andrés ME
    J Neurosci Res; 2003 Sep; 73(5):686-97. PubMed ID: 12929136
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vivo studies of striatal dopamine release and metabolism following administration of L-dopa.
    Brannan T; Knott P; Kaufmann H; Yahr M
    Adv Neurol; 1990; 53():75-81. PubMed ID: 2173378
    [No Abstract]   [Full Text] [Related]  

  • 50. Lack of permanent nigrostriatal dopamine deficit following 6-hydroxydopamine injection into the rat striatum. Short communication.
    Opacka-Juffry J; Ashworth S; Sullivan AM; Banati RB; Blunt SB
    J Neural Transm (Vienna); 1996; 103(12):1429-34. PubMed ID: 9029409
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased dopamine metabolism in rat striatum after infusions of substance P into the substantia nigra.
    Waldmeier PC; Kam R; Stöcklin K
    Brain Res; 1978 Dec; 159(1):223-7. PubMed ID: 728796
    [No Abstract]   [Full Text] [Related]  

  • 52. Localization of opiate receptors and enkephalins in the rat striatum in relationship with the nigrostriatal dopaminergic system: lesion studies.
    Pollard H; Llorens C; Schwartz JC; Gros C; Dray F
    Brain Res; 1978 Aug; 151(2):392-8. PubMed ID: 209865
    [No Abstract]   [Full Text] [Related]  

  • 53. Rotational behavior induced by cocaine analogs in rats with unilateral 6-hydroxydopamine lesions of the substantia nigra: dependence upon dopamine uptake inhibition.
    Heikkila RE; Cabbat FS; Manzino L; Duvoisin RC
    J Pharmacol Exp Ther; 1979 Oct; 211(1):189-94. PubMed ID: 573788
    [No Abstract]   [Full Text] [Related]  

  • 54. Two kinds of nigrostriatal asymmetry: relationship to dopaminergic drug sensitivity and 6-hydroxydopamine lesion effects in Long-Evans rats.
    Glick SD; Hinds PA; Baird JL
    Brain Res; 1988 May; 450(1-2):334-41. PubMed ID: 3135915
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Release of endogenously synthesized catechols from the caudate nucleus by stimulation of the nigro-striatal pathway and by the administration of d-amphetamine.
    Chiueh CC; Moore KE
    Brain Res; 1973 Feb; 50(1):221-5. PubMed ID: 4690549
    [No Abstract]   [Full Text] [Related]  

  • 56. Specificity of 6-hydroxydopamine induced degeneration of central monoamine neurones: an electron and fluorescence microscopic study with special reference to intracerebral injection on the nigro-striatal dopamine system.
    Hökfelt T; Ungerstedt U
    Brain Res; 1973 Oct; 60(2):269-97. PubMed ID: 4763613
    [No Abstract]   [Full Text] [Related]  

  • 57. Demonstration of a pallido-nigral projection innervating dopaminergic neurons.
    Hattori T; Fibiger HC; McGeer PL
    J Comp Neurol; 1975 Aug; 162(4):487-504. PubMed ID: 50334
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Sirinathsinghji DJ; Whittington PE; Audsley AR
    Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Behavioral, physiological, and neurochemical changes after 6-hydroxydopamine-induced degeneration of the nigro-striatal dopamine neurons.
    Ungerstedt U; Ljungberg T; Steg G
    Adv Neurol; 1974; 5():421-6. PubMed ID: 4531217
    [No Abstract]   [Full Text] [Related]  

  • 60. Immunohistochemical detection of L-DOPA-derived dopamine within serotonergic fibers in the striatum and the substantia nigra pars reticulata in Parkinsonian model rats.
    Yamada H; Aimi Y; Nagatsu I; Taki K; Kudo M; Arai R
    Neurosci Res; 2007 Sep; 59(1):1-7. PubMed ID: 17586078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.